Reuters logo
10 个月前
BRIEF-Roche says first phase III data on tecentriq to feature at the ESMO Congress
2016年10月3日 / 凌晨5点11分 / 10 个月前

BRIEF-Roche says first phase III data on tecentriq to feature at the ESMO Congress

1 分钟阅读

Oct 3 (Reuters) - Roche Holding Ag

* Roche media release: first phase III data on Roche's TECENTRIQ (atezolizumab) to feature at the 2016 European Society for Medical Oncology (ESMO) Congress Source text for Eikon: [here ] Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below